Browse > Article

ADENOVIRAL VECTOR MEDIATED IN VIVO GENE TRANSFER OF BDNF PROMOTE FUNCTIONAL RECOVERY AFTER FACIAL NERVE CRUSH INJURY  

Yang, Byoung-Eun (Department of Oral and Maxillofacial Surgery, College of Medicine, Hallym University)
Lee, Jong-Ho (Department of Oral and Maxillofacial Surgery, Graduate School of Dentistry, Seoul National University)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.32, no.4, 2006 , pp. 308-316 More about this Journal
Abstract
Objectives Despite considerable advances in technique, experience and skill, the precise place of surgery in the treatment of facial nerve injury remains uncertain. We designed a facial nerve crush injury model in rats and evaluated the recovery of crushed nerve which is the most common injury type of facial nerve using adenovirus vector mediated in vivo gene transfer of Brain derived neurotrophic factor(BDNF). Materials and methods In 48 Sprague Dawley rats, we made a facial nerve crush injury model to main trunk before the furcation, and injected a $10^{11}$pfu adenoviral BDNF in experimental group(BDNF adenoviral injection group; ad-BDNF) and $3{\mu}l$ saline in control group(Saline injection group; saline). After a period of regeneration from 10 to 40 days, nerve regeneration was evaluated with functioinal test (vibrissae and ocular movement), electrophysiologic study(threshold, peak voltage, conduction velocity) and histomorphometric study of axon density. Results Vibrissae and ocular movement, threshold and conduction velocity improved as time elapse in both group, however axon density was increased significantly only in experimental group. Functional test in 10 days and 20 days showed no difference between experimental group and control group. Vibrissae movement, threshold, conduction velocity and axon density in 30 days revealed that the regeneration in quality of experimental group was significantly superior to that of control group. Conclusion In general, there is tendency for nerve regeneration in experimental group (BDNF-adenovirus injection group) during 40 days, functional recovery was detected successfully after facial nerve crush in 30 days postoperatively.
Keywords
Facial nerve regeneration; BDNF; Adenoviral gene transfection; Crush injury;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Adams JH DL, eds. Greenfield's Neuropathology. New York: NY: Oxford University Press; 1992
2 Oppenheim RW, Yin QW, Prevette D, Yan Q: Brain-derived neurotrophic factor rescues developing avian motoneurons from cell death. Nature 1992;360:755-757   DOI   ScienceOn
3 Funakoshi H, Frisen J, Barbany G, Timmusk T, Zachrisson O, Verge VM, Persson H: Differential expression of mRNAs for neurotrophins and their receptors after axotomy of the sciatic nerve. J Cell Biol 1993;123:455-465   DOI
4 Shirley DM, Williams SA, Santos PM: Brain-derived neurotrophic factor and peripheral nerve regeneration: a functional evaluation. Laryngoscope 1996;106:629-632   DOI   ScienceOn
5 Haase G, Pettmann B, Vigne E, Castelnau-Ptakhine L, Schmalbruch H, Kahn A: Adenovirus-mediated transfer of the neurotrophin-3 gene into skeletal muscle of pmn mice: therapeutic effects and mechanisms of action. J Neurol Sci 1998;160 Suppl 1:S97-105   DOI   ScienceOn
6 Boyd JG, Gordon T: Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury. Mol Neurobiol 2003;27:277-324   DOI   ScienceOn
7 Zawadzka M, Kaminska B: Immunosuppressant FK506 affects multiple signaling pathways and modulates gene expression in astrocytes. Mol Cell Neurosci 2003;22:202-209   DOI   ScienceOn
8 Jones LL, Oudega M, Bunge MB, Tuszynski MH: Neurotrophic factors, cellular bridges and gene therapy for spinal cord injury. J Physiol 2001;533:83-89   DOI
9 Peltekian E, Parrish E, Bouchard C, Peschanski M, Lisovoski F: Adenovirus-mediated gene transfer to the brain: methodological assessment. J Neurosci Methods 1997;71:77-84   DOI   ScienceOn
10 Mattsson P, Janson AM, Aldskogius H, Svensson M: Nimodipine promotes regeneration and functional recovery after intracranial facial nerve crush. J Comp Neurol 2001;437:106-117   DOI   ScienceOn
11 Kobayashi NR, Bedard AM, Hincke MT, Tetzlaff W: Increased expression of BDNF and trkB mRNA in rat facial motoneurons after axotomy. Eur J Neurosci 1996;8:1018-1029   DOI   ScienceOn
12 Hadlock TA, Heaton J, Cheney M, Mackinnon SE: Functional recovery after facial and sciatic nerve crush injury in the rat. Arch Facial Plast Surg 2005;7:17-20   DOI   ScienceOn
13 Sugita K, Hirota T, Iguchi I, Mizutani T: Comparative study of the pressure of various aneurysm clips. J Neurosurg 1976;44:723-727   DOI
14 Barde YA, Edgar D, Thoenen H: Purification of a new neurotrophic factor from mammalian brain. Embo J 1982;1:549-553
15 Boyd JG, Gordon T: A dose-dependent facilitation and inhibition of peripheral nerve regeneration by brain-derived neurotrophic factor. Eur J Neurosci 2002;15:613-626   DOI   ScienceOn
16 Poduslo JF, Curran GL: Permeability at the blood-brain and bloodnerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res Mol Brain Res 1996;36:280-286   DOI   ScienceOn
17 Petit F, Paraskevas A, Minns AB, Lee WP, Lantieri LA: Face transplantation: where do we stand? Plast Reconstr Surg 2004;113:1429-1433   DOI   ScienceOn
18 Sendtner M, Holtmann B, Kolbeck R, Thoenen H, Barde YA: Brainderived neurotrophic factor prevents the death of motoneurons in newborn rats after nerve section. Nature 1992;360:757-759   DOI   ScienceOn
19 Smith GM, Romero MI: Adenoviral-mediated gene transfer to enhance neuronal survival, growth, and regeneration. J Neurosci Res 1999;55:147-157   DOI   ScienceOn
20 Gimenezy Ribotta M, Revah F, Pradier L, Loquet I, Mallet J, Privat A: Prevention of motoneuron death by adenovirus-mediated neurotrophic factors. J Neurosci Res 1997;48:281-285   DOI   ScienceOn
21 Markus A, Patel TD, Snider WD: Neurotrophic factors and axonal growth. Curr Opin Neurobiol 2002;12:523-531   DOI   ScienceOn
22 Liu J, Farmer JD, Jr., Lane WS, Friedman J, Weissman I, Schreiber SL: Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991;66:807-815   DOI   ScienceOn
23 Meyer M, Matsuoka I, Wetmore C, Olson L, Thoenen H: Enhanced synthesis of brain-derived neurotrophic factor in the lesioned peripheral nerve: different mechanisms are responsible for the regulation of BDNF and NGF mRNA. J Cell Biol 1992;119:45-54   DOI   ScienceOn
24 Kamijo Y, Koyama J, Oikawa S, Koizumi Y, Yokouchi K, Fukushima N, Moriizumi T: Regenerative process of the facial nerve: rate of regeneration of fibers and their bifurcations. Neurosci Res 2003;46:135-143   DOI   ScienceOn
25 Koda M, Hashimoto M, Murakami M, Yoshinaga K, Ikeda O, Yamazaki M, Koshizuka S, Kamada T, Moriya H, Shirasawa H, Sakao S, Ino H: Adenovirus vector-mediated in vivo gene transfer of brain-derived neurotrophic factor (BDNF) promotes rubrospinal axonal regeneration and functional recovery after complete transection of the adult rat spinal cord. J Neurotrauma 2004;21:329-337   DOI   ScienceOn
26 Hermens WT, Giger RJ, Holtmaat AJ, Dijkhuizen PA, Houweling DA, Verhaagen J: Transient gene transfer to neurons and glia: analysis of adenoviral vector performance in the CNS and PNS. J Neurosci Methods 1997;71:85-98   DOI   ScienceOn
27 Yan Q, Elliott J, Snider WD: Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death. Nature 1992;360:753-755   DOI   ScienceOn